(Q48593330)

13 February 2018

title

FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition. (English)

1 reference

13 February 2018

main subject

hepatocellular carcinoma

1 reference

Jian Wang

1

1 reference

13 February 2018

Chang-Peng Zhu

2

1 reference

13 February 2018

Ping-Fang Hu

3

1 reference

13 February 2018

Hui Qian

4

1 reference

13 February 2018

Bei-Fang Ning

5

1 reference

13 February 2018

Qing Zhang

6

1 reference

13 February 2018

Fei Chen

7

1 reference

13 February 2018

Jiao Liu

8

1 reference

13 February 2018

Bin Shi

9

1 reference

13 February 2018

Xin Zhang

10

1 reference

13 February 2018

Wei-Fen Xie

11

1 reference

13 February 2018

language of work or name

English

0 references

publication date

20 August 2014

1 reference

13 February 2018

published in

Carcinogenesis

1 reference

13 February 2018

volume

35

1 reference

13 February 2018

issue

11

1 reference

13 February 2018

page(s)

2576-2583

1 reference

13 February 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Current approach in the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Expression of HNF-1 alpha and HNF-1 beta in various histological differentiations of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

The initiation of liver development is dependent on Foxa transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Foxa2 regulates multiple pathways of insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Induction of sodium iodide symporter gene and molecular characterisation of HNF3 beta/FoxA2, TTF-1 and C/EBP beta in thyroid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

IKKα activation of NOTCH links tumorigenesis via FOXA2 suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

RETRACTED: Ferroportin in the progression and prognosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

RNA interference against cancer/testis genes identifies dual specificity phosphatase 21 as a potential therapeutic target in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Matrix metalloproteinases and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Interplay between Epigenetics and Genetics in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Forkhead box protein A2 (FOXA2) protein stability and activity are regulated by sumoylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

SIRT1 mediates FOXA2 breakdown by deacetylation in a nutrient-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Matrix metalloproteinases: fold and function of their catalytic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Foxa2 regulates polarity and epithelialization in the endoderm germ layer of the mouse embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

The microenvironment of the tumour-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU180

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGU180

1 reference

13 February 2018

PubMed ID

25142974

1 reference

13 February 2018